Patent directory · USPTO A61K / A61P
Patents matching “The Regents of the University of Colorado”
401 pharma patents match "The Regents of the University of Colorado" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 401 pharmaceutical patents matching "The Regents of the University of Colorado" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11771745
Compositions and methods for treatment of homocystinuria
granted -
US 11738022
Methods for inducing pupil dilation
granted -
US 11701361
p110-delta inhibitors treat and prevent autoimmunity while sparing the ability to mount an immune response to exogenous immunogens
granted -
US 11679093
2-naphthimidamides, analogues thereof, and methods of treatment using same
granted -
US 11642319
Targeted nanogels for urinary bladder therapies
granted -
US 11613502
Core-shell ceramic particle colloidal gel and solid oxide fuel cell electrolyte
granted -
US 11602556
Insulin mimotopes and methods of using the same
granted -
US 11572588
Methods of evaluating treatment efficacy and/or treatment duration in mycobacterial diseases
granted -
US 11566242
Methods and compositions for reprogramming cells
granted -
US 11534429
Small molecule inhibitors of bacterial efflux pumps and methods of using same
granted -
US 11524985
IL-37 fusion protein and methods of making and using same
granted -
US 11497770
Compositions and methods for treating cancer with TSLPR-CD19 or TSLPR-CD22 immunotherapy
granted -
US 11491111
Thermostable vaccine compositions and methods of preparing same
granted -
US 11479772
Thiomorpholino oligonucleotides for the treatment of muscular dystrophy
granted -
US 11471496
Compositions and methods for treating or ameliorating cocaine addiction
granted -
US 11472812
Anti-cancer compounds targeting Ral GTPases and methods of using the same
granted -
US 11466010
Toll-like receptor 8 (TLR8) specific antagonists and methods of making and uses thereof
granted -
US 11459560
Methods and compositions for reprogramming cells
granted -
US 11452709
Compositions and methods for preventing and treating radiation-induced bystander effects caused by radiation or radiotherapy
granted -
US 11433126
Protection from stress, anxiety, neuroinflammation, and cognitive dysfunction
granted -
US 11433038
High concentration medicant solutions for treating neurological disorders
granted -
US 11433088
Methods for treatment of vascular endothelial dysfunction using nicotinamide mononucleotide
granted -
US 11426409
Compounds, compositions and methods for treating or preventing HER-driven drug-resistant cancers
granted -
US 11407820
Modulating the alternative complement pathway
granted